Management of Diabetic Foot Infection with Plant-Based Metabolite
Clicks: 46
ID: 309185
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
13.5
/100
46 views
7 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #4 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diabetic foot infections (DFIs) are severe complications of diabetes mellitus, often resulting in chronic wounds, gangrene, and amputations due to impaired wound healing and immune dysfunction. Conventional therapies, including antibiotics and debridement, are often insufficient and accompanied by side effects, necessitating alternative treatments. This review highlights the potential of plant metabolites, particularly bioactive compounds from Ocimum sanctum (Tulsi) and Catharanthus roseus (Periwinkle), in managing DFIs. Compounds such as eugenol, ursolic acid, rosmarinic acid, and alkaloids exhibit anti-inflammatory, antioxidant, and antimicrobial properties, promoting wound healing through enhanced angiogenesis, collagen synthesis, and fibroblast activity. The integration of these phytochemicals into therapeutic strategies may offer a cost-effective, side-effect-free adjunct to existing treatments for DFIs. Further clinical research is required to validate these findings and establish their efficacy in patient care
| Reference Key |
imported_1761926615_6904ddd7cb5e2
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Uttam Tomar |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.